etodolac has been researched along with indomethacin in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (18.37) | 18.7374 |
| 1990's | 11 (22.45) | 18.2507 |
| 2000's | 20 (40.82) | 29.6817 |
| 2010's | 9 (18.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asselin, AA; Dobson, TA; Humber, LG; Komlossy, J | 1 |
| Demerson, CA; Humber, LG; Martel, RR; Philipp, AH | 1 |
| Brigance, R; Conway, K; Demerson, CA; Hughes, P; Humber, LG; Katz, AH; Labbadia, F; Mobilio, D; Shah, U; Williams, G | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Cihlar, T; Ho, ES; Mulato, AS | 1 |
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Beroza, P; Cai, D; Damodaran, K; Gomez, RF; Hsu, N; Keck, JG; Laborde, E; Lum, RT; Macke, TJ; Martin, G; Schow, SR; Simon, RJ; Villar, HO; Wick, MM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Barton, P; Luker, T; Wenlock, MC | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Kumar, M; Sinha, VR; Thareja, S | 1 |
| Furukawa, T; Hosoya, K; Kadono, K; Moriguchi, H; Nakamori, F; Naritomi, Y; Teramura, T; Terashita, S; Tetsuka, K; Yamano, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Karbowski, A | 1 |
| Kimura, K; Nakamura, Y; Shibata, Y; Yoshida-Suzuka, H | 1 |
| Chang, JY; Elwell, JM; Goldring, MB; Sohbat, E | 1 |
| Ahnfelt-Rønne, I; Skak-Nielsen, T; Thomsen, MK | 1 |
| Dardano, B; Fiore, D; Fiore, L; Gospodinoff, A; Scapato, P | 1 |
| Anderson, SA; Brater, DC; Brown-Cartwright, D; Toto, RD | 1 |
| Lanza, F; Lynn, M; Rack, MF; Sanda, M; Wolf, J | 1 |
| Barkley, M; Kimball, ES; Neuman, RG; Weichman, BM; Wilson, BD; Wood, DD | 1 |
| Beaulieu, G | 1 |
| Borgeat, P; Salari, H; Saura, C; Sirois, P | 1 |
| Hamada, K; Inoue, K; Kimura, K; Shibata, Y; Ueda, F | 1 |
| Dainaka, J; Hashii, H; Inoue, K; Kimura, K; Motonaga, A; Nishimura, T; Ueda, F; Yamate, K | 1 |
| Bacon, P | 1 |
| Fujisawa, H; Inoue, K; Inoue, Y; Kimura, K; Motonaga, A; Nishimura, T; Shibata, Y; Suzuka, H; Ueda, F; Yoshifusa, H | 1 |
| Fuller, J; Gentry, C; Melarange, R; Smith, PH; Toseland, CD | 1 |
| Goasguen, J; Guggenbuhl, P; Jacquelinet, C; Lapicque, F; Le Dantec, P; Netter, P; Pawlotsky, Y; Perdriger, A; Veillard, E | 1 |
| Wallace, JL | 1 |
| Chikazu, D; Hakeda, Y; Kawaguchi, H; Kumegawa, M; Nakamura, K | 1 |
| Dohi, K; Ikeda, Y; Jimbo, H; Matsumoto, K; Sasaki, K; Satoh, K | 1 |
| Browning, RA; Burgess, FW | 1 |
| Keelan, JA; Mitchell, MD; Sato, TA | 1 |
| Harmon, FA; Snyder, JR; Van Hoogmoed, LM | 1 |
| Inoue, N; Matsui, M; Tachibana, M; Ukai, Y; Yano, J; Yoshida, E | 1 |
| Abdel-Salam, OM | 1 |
| Inaba, T; Inoue, M; Kaibori, M; Kamiyama, Y; Kwon, AH; Nakada, H; Ogura, T; Okumura, T; Takada, H; Takeuchi, N; Tanaka, H; Toda, M; Yanagida, H; Yokoigawa, N | 1 |
| Khan, NK; Radi, ZA | 1 |
| Jiang, S; Kamei, C; Rahman, A; Ueda, Y; Yatsuzuka, R | 1 |
| Cho, YW; Choi, SJ; Jeong, SY; Kang, IM; Lee, HS; Lee, HW; Lee, KT; Lee, MJ; Ryu, JH; Seo, JH | 1 |
| Aoki, E; Araki, T; Kato, H; Yano, R; Yokoyama, H | 1 |
| Au, AL; Chan, SW; Kwan, YW; Lee, SM; Leung, GP; Li, RW; Seto, SW; Tse, CM | 1 |
| Banerjee, S; Phaujdar, S; Santra, G; Sarkar, RN; Siddhanta, S | 1 |
3 review(s) available for etodolac and indomethacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etodolac; Gene Expression; Humans; Ibuprofen; Indomethacin; Isoenzymes; Meloxicam; Membrane Proteins; Naproxen; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles | 1999 |
Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Etodolac; Gastrointestinal Tract; Humans; Indomethacin; Naproxen; Species Specificity | 2006 |
4 trial(s) available for etodolac and indomethacin
| Article | Year |
|---|---|
Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Indomethacin; Knee Joint; Male; Middle Aged; Osteoarthritis; Pain | 1991 |
An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.
Topics: Acetates; Adolescent; Adult; Endoscopy; Etodolac; Gastric Mucosa; Humans; Ibuprofen; Indomethacin; Intestinal Mucosa; Middle Aged; Naproxen; Placebos | 1987 |
Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Etodolac; Global Health; Hip Joint; Humans; Indomethacin; Knee Joint; Middle Aged; Naproxen; Osteoarthritis; Pain; Piroxicam; Time Factors | 1993 |
Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chronic Disease; Double-Blind Method; Etodolac; Female; Humans; Indomethacin; Inflammation; Joint Diseases; Linear Models; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 1996 |
42 other study(ies) available for etodolac and indomethacin
| Article | Year |
|---|---|
Cycloalkanoindoles. 1. Syntheses and antiinflammatory actions of some acidic tetrahydrocarbazoles, cyclopentindoles, and cycloheptindoles.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Carbazoles; Cycloheptanes; Cyclopentanes; Edema; Indoles; Rats; Stomach Ulcer; Structure-Activity Relationship | 1976 |
Etodolic acid and related compounds. Chemistry and antiinflammatory actions of some potent di- and trisubstituted 1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole-1-acetic acids.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Carrageenan; Freund's Adjuvant; Indoleacetic Acids; Male; Pyrans; Rats; Stomach Ulcer | 1976 |
Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indo le-1-a cetic acid, a potent analgesic agent.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; In Vitro Techniques; Indoleacetic Acids; Male; Prostaglandins; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
Topics: Adenine; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Biological Transport; Carrier Proteins; Humans; Kidney; Organophosphonates; Structure-Activity Relationship | 2000 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Combinatorial Chemistry Techniques; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Design; Drug Evaluation, Preclinical; Ibuprofen; Inhibitory Concentration 50; Isoenzymes; Models, Molecular; Models, Theoretical; Molecular Structure; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Quantitative Structure-Activity Relationship | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship | 2012 |
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
Topics: Administration, Oral; Biotransformation; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Glucuronides; Glucuronosyltransferase; Humans; Intestinal Absorption; Intestines; Isoenzymes; Kinetics; Metabolic Clearance Rate; Microsomes; Models, Biological; Pharmaceutical Preparations; Recombinant Proteins; Substrate Specificity | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cartilage, Articular; Edema; Etodolac; Indoleacetic Acids; Indomethacin; Male; Mice; Mice, Inbred Strains; Synovial Membrane | 1991 |
Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cartilage; Cells, Cultured; Collagen; Dinoprostone; Etodolac; Fibronectins; Humans; Indoleacetic Acids; Indomethacin; Ketoprofen; Phenotype; Procollagen; RNA, Messenger; Time Factors | 1990 |
Effects of etodolac, indomethacin and sodium salicylate on canine neutrophil function.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Dogs; Etodolac; In Vitro Techniques; Indoleacetic Acids; Indomethacin; Neutrophils; Pancreatic Elastase; Phagocytosis; Salicylates; Salicylic Acid; Superoxides | 1990 |
[Open clinical study on the efficacy and tolerance of acemetacin in rheumatoid arthritis and osteoarthrosis].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Etodolac; Female; Humans; Indoleacetic Acids; Indomethacin; Male; Middle Aged; Osteoarthritis | 1989 |
Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Dinoprostone; Etodolac; Humans; Indomethacin; Ketoprofen; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Liver Cirrhosis, Alcoholic; Prostaglandins E; Sulindac | 1986 |
Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cartilage; Cattle; Cells, Cultured; Dinoprostone; Etodolac; Female; Ibuprofen; Indomethacin; Macrophages; Male; Mice; Mice, Inbred C57BL; Piroxicam; Prostaglandin Antagonists; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Synovial Fluid | 1987 |
Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Etodolac; Heart Rate; Hemodynamics; Indomethacin; Propranolol; Vascular Resistance | 1985 |
Comparative effects of etodolac, indomethacin, and benoxaprofen on icosanoid biosynthesis.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arachidonate Lipoxygenases; Blood Platelets; Catechols; Cyclooxygenase Inhibitors; Etodolac; Guinea Pigs; Humans; Indomethacin; Leukocytes; Lipoxygenase Inhibitors; Lung; Masoprocol; Muscle Contraction; Propionates; SRS-A; Trachea | 1984 |
Effect of anti-inflammatory agent etodolac on antigen-induced contractions of the trachea and lung parenchyma of guinea pigs.
Topics: Animals; Asthma; Benzoquinones; Disease Models, Animal; Etodolac; Guinea Pigs; Immunization, Passive; Indomethacin; Isoantigens; Lipoxygenase Inhibitors; Lung; Methacrylates; Muscle Contraction; Muscle, Smooth; Rabbits; Serum Albumin, Bovine; Thromboxane A2; Trachea | 1994 |
Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
Topics: Animals; Aspirin; Bradykinin; Bromelains; Cartilage, Articular; Cell Line; Concanavalin A; Depression, Chemical; Diclofenac; Dinoprostone; Dogs; Etodolac; Gastric Mucosa; Guinea Pigs; Indomethacin; Interleukin-1; Ketoprofen; Kidney; Naproxen; Oxygen; Pain; Piroxicam; Rabbits; Rats | 1994 |
Effect of etodolac on type-II collagen-induced arthritis in mice.
Topics: Animals; Arthritis, Experimental; Cartilage, Articular; Collagen; Etodolac; Hindlimb; Indomethacin; Male; Mice; Mice, Inbred DBA; Radiography; Tarsus, Animal | 1993 |
Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antilymphocyte Serum; Etodolac; Gastric Mucosa; Gastrointestinal Hemorrhage; Haptoglobins; Ileal Diseases; Indomethacin; Intestinal Mucosa; Male; Neutropenia; Neutrophils; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Ulcer | 1995 |
Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Topics: Acid Phosphatase; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Bone Marrow Cells; Bone Resorption; Calcium; Cells, Cultured; Coculture Techniques; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dentin; Dose-Response Relationship, Drug; Enzyme Induction; Etodolac; Fibroblast Growth Factor 2; Flurbiprofen; Humans; Indomethacin; Isoenzymes; Membrane Proteins; Mice; Nitrobenzenes; Osteoblasts; Osteoclasts; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rabbits; RNA, Messenger; Skull; Sulfonamides; Tartrate-Resistant Acid Phosphatase | 2000 |
Direct superoxide scavenging activity of nonsteroidal anti-inflammatory drugs: determination by electron spin resonance using the spin trap method.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electron Spin Resonance Spectroscopy; Etodolac; Free Radical Scavengers; Headache; Humans; In Vitro Techniques; Indomethacin; Isoenzymes; Membrane Proteins; Phenylpropionates; Prostaglandin-Endoperoxide Synthases; Spin Trapping; Superoxides | 2001 |
Nonsteroidal anti-inflammatory drugs for perioperative pain control.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Humans; Ibuprofen; Indomethacin; Ketorolac; Lactones; Nabumetone; Naproxen; Pain, Postoperative; Piroxicam; Pyrazoles; Sulfonamides; Sulfones; Time Factors | 2001 |
Regulation of prostaglandin production in an immortalized human myometrial cell line by cytokines and non-steroidal anti-inflammatory drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Enzyme Inhibitors; Etodolac; Female; Furans; Humans; Indomethacin; Interleukin-1; Prostaglandins; Sulfonamides; Tumor Necrosis Factor-alpha | 2002 |
In vitro investigation of the effects of cyclooxygenase-2 inhibitors on contractile activity of the equine dorsal and ventral colon.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Colon; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etodolac; Horses; In Vitro Techniques; Indomethacin; Isoenzymes; Muscle Contraction; Muscle, Smooth; Nabumetone; Prostaglandin-Endoperoxide Synthases | 2002 |
Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Diclofenac; Edema; Etodolac; Gastric Mucosa; Indomethacin; Male; Meloxicam; Mice; Peptic Ulcer; Rats; Species Specificity; Thiazines; Thiazoles | 2003 |
Anti-inflammatory, antinociceptive, and gastric effects of Hypericum perforatum in rats.
Topics: Acetic Acid; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Carrageenan; Drug Evaluation, Preclinical; Edema; Electroshock; Etodolac; Fluoxetine; Gastric Acid; Gastric Mucosa; Hot Temperature; Hypericum; Indomethacin; Pain; Peritonitis; Plant Extracts; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stomach Ulcer | 2005 |
Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream.
Topics: Amino Acid Sequence; Blood Proteins; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Etodolac; Gastrointestinal Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Molecular Sequence Data; Monocytes; Mucins; Oligopeptides; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfoglycosphingolipids | 2007 |
Involvement of cyclooxygenase-2 in allergic nasal inflammation in rats.
Topics: Animals; Carbazoles; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Electroencephalography; Etodolac; Hypersensitivity; Indoles; Indomethacin; Leukotriene Antagonists; Male; Olfactory Bulb; Ovalbumin; Phenylcarbamates; Rats; Rats, Wistar; Receptors, Thromboxane A2, Prostaglandin H2; Rhinitis; Sneezing; Sulfonamides; Tosyl Compounds | 2006 |
Development and validation of a high performance liquid chromatography-tandem mass spectrometry for the determination of etodolac in human plasma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Etodolac; Humans; Indomethacin; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2008 |
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Cyclooxygenase Inhibitors; Dopamine; Edaravone; Enzyme Activators; Enzyme Inhibitors; Etodolac; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Homovanillic Acid; Indazoles; Indoles; Indomethacin; Male; Mice; Mice, Inbred C57BL; Minocycline; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Quinolines | 2008 |
Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells.
Topics: Adenosine; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Cell Proliferation; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Etodolac; Humans; Indomethacin; Inhibitory Concentration 50; Ketoprofen; Kinetics; Mefenamic Acid; Muscle, Smooth, Vascular; Piroxicam; Sulindac; Temperature; Tetrazolium Salts; Thiazoles; Thioinosine | 2009 |
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Cyclooxygenase 2 Inhibitors; Diclofenac; Diphosphonates; Etodolac; Female; Health Status Indicators; Humans; Indomethacin; Male; Pamidronate; Prospective Studies; Spondylitis, Ankylosing; Treatment Failure; Tumor Necrosis Factor-alpha; Young Adult | 2010 |